Health
AstraZeneca’s Soriot Warns US Against Trade Tariffs on Drugs
This article is for subscribers only.
Supply Lines is a daily newsletter that tracks global trade. Sign up here.
AstraZeneca Plc’s Chief Executive Officer Pascal Soriot warned that trade tariffs are not the best way to manage pharmaceuticals and that drugmakers are calling for no additional US levies on medicines.